Aesthetics

This week in aesthetics, we highlight Zoom dysmorphia, laser considerations for skin of color, and more.

Catch up on all of the latest aesthetic news coming out of the American Academy of Dermatology Virtual Meeting Experience 2021 (AAD VMX 2021).

Revance presents 4 AAD VMX ePoster abstracts examining phase 3 study data for DAXI, and the impact of HA filler manufacturing technologies on HA chain degradation.

Physicians must learn how to tailor treatments and assess skin of color risk to best serve the POC patient population. Doing so will deliver positive outcomes and drive patient satisfaction.

Microneedling with or without radiofrequency energy has become a very popular cosmetic procedure. Understanding the science behind these versatile devices can help clinicians better harness their therapeutic potential and ensure positive treatment outcomes in their patients.

Patients are referencing video conferencing as the reason for seeking cosmetic consultation since the beginning of the pandemic.

This week, consumer magazines highlight SkinTok diversity issues, a personal account of getting lip filler after years of lip dissatisfaction, and more.

A survey found a large proportion of dermatologists surveyed said their patients referenced video conferencing as the reason for seeking cosmetic consultation since the start of the pandemic.

Patients of color make up a growing market for aesthetic dermatology. Physicians must learn how to tailor treatments and assess skin of color risk to best serve this emerging patient population. Doing so will deliver positive outcomes and drive patient satisfaction.

Futuristic tools including robotics and new types of lasers are just some of the therapeutic innovations aimed at slowing hair loss and increasing hair growth.

New data on the safety and efficacy of roflumilast foam (ARQ-154, Arcutis Biotherapeutics) for scalp and body psoriasis was presented at the American Academy of Dermatology Virtual Meeting Experience (AAD VMX) 2021.

This week in aesthetics, we highlight The Box by Dr. Ava, the role of sun protection in skin cancer prevention, and more.

With the summer months quickly approaching, Melissa Stenstrom, MD, discusses the importance of skin cancer screenings, as well as encouraging regular sun protection usage among patients. She also touches on the role of telemedicine in skin cancer screenings, top product recommendations for sun protection, and tips on managing patient expectations if diagnosed with skin cancer.

Phase 2 data adds to evidence showing efficacy of JAK inhibitors for treating alopecia areata, for which there are no FDA-approved treatments.

Ava Shamban, MD, makes dermatologist recommended skin care and wellness products more accessible with the creation of her quarterly skin care box, The Box by Dr. Ava.

This week, consumer magazines highlight hyperhidrosis, filler questions to ask a dermatologist, and more.

This week in aesthetics, we highlight baricitinib for hair regrowth in alopecia areata patients, the April “Meet the Aesthetic Expert” column, and more.

In this monthly technology review, Michael Kluska, DO, discusses Evolve by InMode, including device overview, cost, ROI, patient perceptions, and candidate considerations.

In this month’s "Meet the Aesthetic Expert" column, Will Kirby, DO, FAOCD, talks with dual board-certified dermatologist and dermatopathologist Amy Spizuoco, DO, FAOCD, FAAD, about her new role as president-elect of AOCD, the coveted millennial patient population, and how to leverage health and beauty for a more holistic approach to aesthetics.

A recent study in the Journal of Cosmetic Dermatology examines the safety and efficacy of using vitamin D intralesional injection for the treatment of keloid scars.

This week, consumer magazines highlight why millennials are opting for surgical brow lifts over noninvasive treatments, the merger of clinical and clean skin care, and more.

This week in aesthetics, we highlight hair transplantation devices, laser technology purchases, and more.

Eli Lilly and Incyte announce results from its phase 3 study evaluating baricitinib 2 mg and 4 mg for the treatment of alopecia areata, making it the first Phase 3 study with top-line results in patients with the hair disorder.

Nicole Hayre, MD, FAAD, discusses her research on the link between oxytocin and younger-looking skin.

In this episode, Nicole Hayre, MD, FAAD, discusses her research on the link between the "love hormone" oxytocin and younger-looking skin.